Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix

• US 5,993,844 A
• Filed: 05/08/1997
• Issued: 11/30/1999
• Est. Priority Date: 05/08/1997
• Status: Expired due to Term

• Current Assignee: Organogenesis Inc. (Organogenesis Holdings, Inc.)
• Original Assignee: Organogenesis Inc. (Organogenesis Holdings, Inc.)
• Inventors: Carr, Robert M. Jr., Mercer, Ryan, Baker, Linda, Abraham, Ginger A., Kemp, Paul D.
• Primary Examiner(s): Saucier, Sandra E.
• Application Number:
  US08/853,372
• Time in Patent Office: 936 Days
• Field of Search: 424/422, 424/423, 623/2, 623/11, 435/1.1
• US Class Current: 424/423
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: A61K 38/39 Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
• CPC Class Codes: A61L 2430/40 Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
• CPC Class Codes: A61L 27/24 Collagen
• CPC Class Codes: A61L 27/3687 characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
• CPC Class Codes: A61L 27/3695 characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this A61L27/3687, A61L27/3691 take precedence
• CPC Class Codes: Y10S 623/917 Collagen
• CPC Class Codes: Y10S 623/92 Method or apparatus for preparing or treating prosthetic

Abstract

The invention is directed to collagenous tissues which have been treated to remove non-collagenous components such as cells, cellular debris, and other extracellular matrix components, such as proteoglycans and glycosaminoglycans, normally found in native tissues. Treatment of the tissue with alkali, chelating agents, acids and salts removes non-collagenous components from the collagenous tissue matrix while controlling the amount of swelling and dissolution so that the resultant collagen matrix retains its structural organization, integrity and bioremodelable properties. The process circumvents the need to use detergents and enzymes which detrimentally affect the cell compatibility, strength and bioremodelability of the collagen matrix. The collagenous tissue matrix is used for implantation, repair, or use in a mammalian host.

Claims

1. A detergent-free and enzyme-free method for the removal of non-collagenous components from native mammalian tissue to yield an essentially collagenous tissue matrix that maintains its structural integrity, comprising:

(a) contacting the tissue with an alkaline solution containing a chelating agent selected from the group consisting of ethylenediaminetetraacetic acid and ethylenebis(oxyethylenitrilo)tetraacetic acid wherein the concentration of the chelating agent in the alkaline solution is between about 1 to about 200 mM and wherein the pH of the solution is between about 8 to about 12;

(b) contacting the tissue with an acidic solution containing a salt wherein the concentration of the salt in the acidic solution is between about 0.1 to about 2 M and wherein the pH of the solution is between 0 and about 1;

(c) contacting the tissue with a salt solution with a pH between about 5 and about 9; and

,

(d) contacting the tissue with a rinse agent, wherein the tissue maintains its structural integrity.

2. The method of claim 1 wherein the concentration of the chelating agent is between about 50 to about 150 mM.

3. The method of claim 1 wherein the alkaline solution of step (a) contains an alkali selected from the group consisting of sodium hydroxide, calcium hydroxide, sodium carbonate or sodium peroxide.

4. The method of claim 3 wherein the concentration of the alkaline agent is between about 0.001 to about 1 M.

5. The method of claim 1 wherein the acidic solution of step (b) is selected from the group consisting of hydrochloric acid, acetic acid and sulfuric acid.

6. The method of claim 5 wherein the concentration of the acid in the acidic solution is between about 0.5 to about 2 M.

7. The method of claim 5 wherein the concentration of the acid in the acidic solution between about 0.95 to about 1.25 M.

8. The method of claim 5 wherein the concentration of the acid in the acidic solution is around 1 M.

9. The method of claim 1 wherein the pH of the acid-salt solution is between 0 and 0.75.

10. The method of claim 1 wherein the pH of the acid-salt solution is between 0.1 to about 0.5.

11. The method of claim 1 wherein the salt of either of steps (b) or (c) is an inorganic salt.

12. The method of claim 1 wherein the salt of either of steps (b) or (c) is selected from the group consisting of sodium chloride, calcium chloride, potassium chloride and ammonium sulfate.

13. The method of claim 1 wherein the salt of either of steps (b) or (c) is at a concentration between about 0.1 to about 2 M.

14. The method of claim 1 wherein the salt of either of steps (b) or (c) is at a concentration 0.75 to about 1.25 M.

15. The method of claim 1 wherein the salt of either of steps (b) or (c) is at a concentration around 1 M.

16. The method of claim 1 wherein said tissue is selected from the group consisting of dermis, artery, vein, pericardium, heart valve, dura mater, ligament, bone, cartilage, fascia and intestine.

17. The method of claim 16 wherein said intestinal tissue comprises the tunica submucosa of the small intestine.

18. The method of claim 16 wherein said tissue is human, bovine, porcine, ovine, canine, caprine, or equine derived.

19. The method of claim 1 wherein the rinse agent is selected from the group consisting of water and a saline solution.

20. The method of claim 1 wherein step (b) is performed before step (a).

22. A bioremodelable collagenous tissue matrix obtained by the method of claim 1 or 21.

21. A detergent-free and enzyme-free method for the removal of non-collagenous components from native mammalian tissue to yield an essentially collagenous tissue matrix that maintains its structural integrity, comprising:

(a) contacting the tissue with a basic solution of ethylenediaminetetraacetic acid at a pH between about 8 and about 12;

(b) contacting the tissue with an acidic solution of sodium chloride at a pH between about 0 and about 1;

(c) contacting the tissue with a solution of sodium chloride at a pH between about 5 and about 9; and

,

(d) rinsing the tissue,

wherein the tissue maintains its structural integrity.

23. A bioremodelable collagenous tissue matrix composition derived from native tissue selected from the group consisting of dermis, artery, vein, pericardium, heart valve, dura mater, ligament, bone, cartilage, fascia and intestine,

wherein the collagenous tissue matrix is free of detergent residues, enzymatic modification and cells and cellular debris;

and comprises

telopeptide collagen;

elastin, wherein elastin is less than 10% of the total composition based on dry weight; and

,

non-collagenous and non-elastinous components wherein said components are less than 5% of the total composition based on dry weight.